{
  "ticker": "JNJ",
  "target_date": "2025-08-26",
  "actual_date": "2025-08-26",
  "collected_at": "2025-12-08T12:11:27.153628",
  "price": {
    "open": 175.63,
    "high": 176.04,
    "low": 174.66,
    "close": 175.3765106201172,
    "volume": 9145000,
    "change_1d_pct": -0.35,
    "change_7d_pct": 0.65,
    "change_30d_pct": 14.57
  },
  "technicals": {
    "rsi_14": 77.54,
    "sma_20": 171.46,
    "sma_50": 162.25,
    "macd": 3.956,
    "macd_signal": 4.026,
    "macd_histogram": -0.069,
    "bb_upper": 179.93,
    "bb_lower": 162.98,
    "price_vs_sma20_pct": 2.29,
    "price_vs_sma50_pct": 8.09,
    "volume_ratio": 1.06
  },
  "fundamentals": {
    "market_cap": 488062943232,
    "pe_ratio": 19.553572,
    "forward_pe": 19.110847,
    "price_to_book": 6.1485114,
    "price_to_sales": 5.296454,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.52,
    "pct_from_52w_low": 44.0
  },
  "macro": {
    "spy": {
      "price": 643.38,
      "change_1d_pct": 0.42,
      "change_7d_pct": 0.29
    },
    "vix": {
      "level": 14.62,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.26
    },
    "dollar_index": {
      "level": 98.23
    },
    "gold": {
      "price": 3388.6
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More",
      "source": "Yahoo",
      "datetime": 1756223880,
      "summary": "The report highlights opportunities in strategic investment and optimizing trial locations. It identifies key clinical trial trends and successes globally, aiding competitive positioning and efficient allocation of resources in the global therapeutics market.Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) --",
      "url": "https://finnhub.io/api/news?id=73892cb07a90c61e243a34982a4d468fe4894d36f87fabfc48cdc0640aeeea0c"
    },
    {
      "headline": "2 High-Conviction Picks For 7.73% Growth And 4.22% Yield Within A Dividend Portfolio",
      "source": "SeekingAlpha",
      "datetime": 1756220400,
      "summary": "Through DPSTF and META, we increased Dividend Income Accelerator Portfolio's sector diversification and global exposure. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=3452d5cd9b4cf8d4251a0ea48074df10fe22dad78a44764ff71b7843f2de36f2"
    },
    {
      "headline": "ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression",
      "source": "Yahoo",
      "datetime": 1756210080,
      "summary": "AbbVie is acquiring Gilgamesh's lead psychedelic drug bretisilocin for up to $1.2B, aiming to expand its depression treatment pipeline",
      "url": "https://finnhub.io/api/news?id=fa42595c1177faf797db732ed7f6e1b1b7467bbf223251dfe67cc5f10483f65a"
    },
    {
      "headline": "Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference",
      "source": "Yahoo",
      "datetime": 1756209600,
      "summary": "SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company\u2019s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Co",
      "url": "https://finnhub.io/api/news?id=7ccbd40f72e80b24e503e3f5f7295e0a289f6cd35d6966c8b619df6f6e86f452"
    },
    {
      "headline": "J&J earmarks $2B for Fujifilm\u2019s North Carolina facility",
      "source": "Yahoo",
      "datetime": 1756209240,
      "summary": "The 10-year deal will expand the biopharma giant\u2019s capacity to better meet U.S. demand for advanced medicines and create 120 jobs for the Raleigh area.",
      "url": "https://finnhub.io/api/news?id=05b5abc2be75b243b5612af3a06f9a3b2a84e6172eb4c56cd993b8643484b686"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-25",
      "description": "xslF345X05/wk-form4_1756163533.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000182/xslF345X05/wk-form4_1756163533.xml"
    },
    {
      "form": "4",
      "date": "2025-08-18",
      "description": "xslF345X05/wk-form4_1755555550.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}